Pramocaine

Pramocaine
Clinical data
Trade namesAnalpram HC, Caladryl, Caladryl Clear, Cortane-B, Epifoam, Gold Bond Maximum Relief, Itch-X, Pramosone, Prax, Proctodan-HC, Proctofoam, Tronolane, Vagisil Medicated
AHFS/Drugs.comInternational Drug Names
MedlinePlusa682429
License data
Routes of
administration
Topical, rectal, Vaginal
ATC code
Legal status
Legal status
  • Depends on country, some formulations OTC others Rx only
Identifiers
  • 4-[3-(4-Butoxyphenoxy)propyl]morpholine
CAS Number
PubChem CID
DrugBank
ChemSpider
UNII
KEGG
ChEBI
ChEMBL
CompTox Dashboard (EPA)
ECHA InfoCard100.004.933 Edit this at Wikidata
Chemical and physical data
FormulaC17H27NO3
Molar mass293.407 g·mol−1
3D model (JSmol)
  • O(c2ccc(OCCCN1CCOCC1)cc2)CCCC
  • InChI=1S/C17H27NO3/c1-2-3-12-20-16-5-7-17(8-6-16)21-13-4-9-18-10-14-19-15-11-18/h5-8H,2-4,9-15H2,1H3 checkY
  • Key:DQKXQSGTHWVTAD-UHFFFAOYSA-N checkY
 ☒NcheckY (what is this?)  (verify)

Pramocaine (INN and BAN, also known as pramoxine or pramoxine HCl) is a topical anesthetic discovered at Abbott Laboratories in 1953[1] and used as an antipruritic. During research and development, pramocaine hydrochloride stood out among a series of alkoxy aryl alkamine ethers as an especially good topical local anesthetic agent.[1] Pharmacologic study revealed it to be potent and of low acute and subacute toxicity, well tolerated by most mucous membranes and of a low sensitizing index in humans.[1] Like other local anesthetics, pramocaine decreases the permeability of neuronal membranes to sodium ions, blocking both initiation and conduction of nerve impulses. Depolarization and repolarization of excitable neural membranes is thus inhibited, leading to numbness.

  1. ^ a b c Schmidt JL, Blockus LE, Richards RK (1953). "The Pharmacology of Pramoxine Hydrochloride: A New Topical Local Anesthetic". Current Researches in Anesthesia & Analgesia. 32 (6:1): 418–25. PMID 13107298.